The IMPACT-AD program will aim to make the clinical trials’ workforce as diverse and representative as its participants. (Illustration/iStock) USC Alzheimer’s disease researchers have joined [...]
Dear ATRI Community, The recent tragedies of George Floyd, Ahmaud Arbery and Breonna Taylor demand that we all address the injustice in our society. These terrible events have [...]
Paul Aisen, MD, director of the Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine at USC, will oversee a study of a new drug in [...]
(Photo credit: iStock) The Journal of Prevention of Alzheimer’s Disease published a study by Paul Aisen, MD, professor of neurology and director of the Keck School’s Alzheimer’s Therapeutic Research Institute [...]
Colored light micrograph of brain tissue from an Alzheimer's disease sufferer. Both of the classic pathological features of this disease are seen here. Both of these abnormalities [...]
An online tool that helps older people monitor their brain health has been developed at the Keck School of Medicine of USC with other medical groups.
The USC Alzheimer’s Therapeutic Research Institute (USC ATRI) brought together the top minds working to find a cure for a disease that affects more than 5 million Americans at its annual partnership meeting in San Diego early this month.
Paul Aisen is one of three principal investigators that will be collaborating on Alzheimer's research with a $70 million grant from the National Institutes of Health. (USC [...]